| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MBII | Common Stock | Sale | $25,000 | -24,510 | -1.1% | $1.02 | 2,208,363 | 24 Aug 2021 | Direct | F1, F2 |
| holding | MBII | Common Stock | 6,442 | 24 Aug 2021 | See Footnote | F3 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.00 to $1.03, inclusive. The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F3 | Ownership is held by Florence H. Marrone TOD Pamela G. Marrone. |